Cover Image

Use of atypical antipsychotics in the treatment of schizophrenia in the Brazilian National Health System: a cohort study, 2008-2017

Abstract Objective: to investigate sociodemographic and clinical characteristics of users of atypical antipsychotics receiving care via the Specialized Component of Pharmaceutical Assistance (Componente Especializado da Assistência Farmacêutica - CEAF), for the treatment of schizophrenia in Brazil...

Full description

Saved in:

Bibliographic Details
Main Authors:	Izabela Fulone (Author), Marcus Tolentino Silva (Author), Luciane Cruz Lopes (Author)
Format:	Book
Published:	Ministério da Saúde do Brasil, 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil
by: Izabela Fulone, et al.
Published: (2021)

New atypical antipsychotics for schizophrenia: iloperidone
by: Silvio Caccia, et al.
Published: (2010)

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
by: I. A. Vilyum, et al.
Published: (2018)

The effects of antipsychotic drugs on depression level in patients with schizophrenia: clozapine vs. other atypical antipsychotics
by: Hülya Ertekin, et al.
Published: (2016)

Risks of Adverse Neonatal Outcomes in Early Adolescent Pregnancy Using Group Prenatal Care as a Strategy for Public Health Policies: A Retrospective Cohort Study in Brazil
by: Danylo José Palma Honorato, et al.
Published: (2021)

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
by: O'Day K, et al.
Published: (2013)

Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand
by: Boonlue T, et al.
Published: (2016)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
by: Anastasiia S. Boiko, et al.
Published: (2021)

Asenapine: an atypical antipsychotic with atypical formulations
by: Meghan Musselman, et al.
Published: (2021)

Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics-The Pilot Case Series Study
by: Marek Krzystanek, et al.
Published: (2021)

Effect of atypical antipsychotic on blood pressure in inpatients with schizophrenia of Prof. Dr. Soerojo Mental Health Hospital Magelang
by: Haafizah Dania, et al.
Published: (2019)

Anti-stress Properties of Atypical Antipsychotics
by: Alice Sanson, et al.
Published: (2020)

Antipsychotics and Mortality in Adult and Geriatric Patients with Schizophrenia
by: Ling-Ling Yeh, et al.
Published: (2023)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
by: Norio Yasui‐Furukori, et al.
Published: (2020)

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
by: I. A. Vilyum, et al.
Published: (2018)

COST AND EFFECTIVENESS OF ATYPICAL-ATYPICAL ANTIPSYCHOTIC COMBINATIONS AND ATYPICAL-TYPICAL ANTIPSYCHOTIC COMBINATIONS IN PATIENTS OF PSYCHOTIC DISORDERS IN INSTALLATION OF EMERGENCY IN GRHASIA MENTAL HOSPITAL, YOGYAKARTA
by: Arya Dibyo Adisaputra, et al.
Published: (2021)

Influence of the use of atypical antipsychotics in metabolic syndrome
by: P Doménech-Matamoros
Published: (2020)

Clozapine: A special case of an atypical antipsychotic
by: Elina Marinho
Published: (2024)

Effect of atypical antipsychotics on glucose and lipid metabolism
by: Madoka Fujimaki, et al.
Published: (2012)

Influence of Antipsychotic Agents on the Sexuality of Patients Diagnosed with Schizophrenia
by: Jaballah Fares, et al.
Published: (2023)

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
by: Lally J, et al.
Published: (2016)

The place of long-acting injectable antipsychotics in the treatment of schizophrenia
by: John M. Kane, et al.
Published: (2023)

Long-acting antipsychotic treatments: focus on women with schizophrenia
by: Sofia Brissos, et al.
Published: (2024)

Cost-Effectiveness of Aripiprazole Tablets with Sensor versus Oral Atypical Antipsychotics for the Treatment of Schizophrenia Using a Patient-Level Microsimulation Modeling Approach
by: Chopra AS, et al.
Published: (2023)

Limitations in the comparison of the Brazilian National Dietary Surveys of 2008-2009 and 2017-2018
by: Renata Muniz Rodrigues, et al.
Published: (2021)

Effect of Atypical Antipsychotics on Fetal Growth: Is the Placenta Involved?
by: Sandeep Raha, et al.
Published: (2012)

Are atypical antipsychotic medications better than the conventional ones?
by: Pedro Miguel Milián Vázquez, et al.
Published: (2005)

Are atypical antipsychotic medications better than the conventional ones?
by: Pedro Miguel Milián Vázquez, et al.
Published: (2005)

Cognitive symptoms associated with antipsychotic course experience in residual schizophrenia
by: D. Safonov
Published: (2021)

Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medication
by: Elnaz Faramarzi, et al.
Published: (2020)

Prescription of antipsychotics and prevalence of metabolic syndrome in Vietnamese inpatients with schizophrenia
by: Nguyen Thi Minh Thuan, et al.
Published: (2022)

Patterns and predictors of oral antipsychotic prescribing in adult patients with schizophrenia
by: Nina Vadiei, et al.
Published: (2022)

Clozapine-Induced Phototoxicity: An Unusual Side Effect of Atypical Antipsychotics
by: S. Al-Aojan, et al.
Published: (2018)

The atypical antipsychotics and sexual dysfunction: a pharmacovigilance-pharmacodynamic study
by: Yu Cheng, et al.
Published: (2024)

Onset of action of atypical and typical antipsychotics in the treatment of acute psychosis
by: Seyed Ghafur Mousavi, et al.
Published: (2013)

Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics
by: Francisco José Toja-Camba, et al.
Published: (2021)

The impact of atypical antipsychotics on the development of type 2 diabetes mellitus
by: Sabina E. Kurtmambetova, et al.
Published: (2024)

Time to rehospitalization in involuntarily hospitalized individuals suffering from schizophrenia discharged on long-acting injectable antipsychotics or oral antipsychotics
by: Ching-Hua Lin, et al.
Published: (2022)

A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia
by: Caccia S, et al.
Published: (2013)

Effects of an Atypical Antipsychotic, Zotepine, on Astroglial L-Glutamate Release through Hemichannels: Exploring the Mechanism of Mood-Stabilising Antipsychotic Actions and Antipsychotic-Induced Convulsion
by: Kouji Fukuyama, et al.
Published: (2021)